Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription
Edelmann, Jennifer, Holzmann, Karlheinz, Tausch, Eugen, Saunderson, Emily A, Jebaraj, Billy M C, Steinbrecher, Daniela, Dolnik, Anna, Blätte, Tamara J, Landau, Dan A, Saub, Jenny, Estenfelder, Sven, Ibach, Stefan, Cymbalista, Florence, Leblond, Veronique, Delmer, Alain, Bahlo, Jasmin, Robrecht, Sandra, Fischer, Kirsten, Goede, Valentin, Bullinger, Lars, Wu, Catherine J, Mertens, Daniel, Ficz, Gabriella, Gribben, John G, Hallek, Michael, Döhner, Hartmut, Stilgenbauer, Stephan
Published in Haematologica (Roma) (01.05.2020)
Published in Haematologica (Roma) (01.05.2020)
Get full text
Journal Article
Phase I/II trial of lenalidomide, methotrexate, leucovorin, cytarabine, and rituximab (LeMLAR) in relapsed or refractory diffuse large B cell lymphoma
Dührsen, Ulrich, Tometten, Mareike, Kroschinsky, Frank, Ganser, Arnold, Ibach, Stefan, Bertram, Stefanie, Hüttmann, Andreas
Published in Blood cancer journal (New York) (17.05.2021)
Published in Blood cancer journal (New York) (17.05.2021)
Get full text
Journal Article
Unicentric Retrospective Analysis of 130 Patients with Extramedullary Multiple Myeloma (EMM)
Zolnowski, Dominik, Karp, Simone, Warncke, Paul, Zinn, Jessica, Pannach, Marcel, Herbst, Regina, Hänel, Annette, Morgner, Anke, Ibach, Stefan, Fricke, Stephan, Hänel, Mathias
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer
Knödler, Maren, Körfer, Justus, Kunzmann, Volker, Trojan, Jörg, Daum, Severin, Schenk, Michael, Kullmann, Frank, Schroll, Sebastian, Behringer, Dirk, Stahl, Michael, Al-Batran, Salah-Eddin, Hacker, Ulrich, Ibach, Stefan, Lindhofer, Horst, Lordick, Florian
Published in British journal of cancer (01.08.2018)
Published in British journal of cancer (01.08.2018)
Get full text
Journal Article
Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial
Herling, Carmen D, Cymbalista, Florence, Groß-Ophoff-Müller, Carolin, Bahlo, Jasmin, Robrecht, Sandra, Langerbeins, Petra, Fink, Anna-Maria, Al-Sawaf, Othman, Busch, Raymonde, Porcher, Raphael, Cazin, Bruno, Dreyfus, Brigitte, Ibach, Stefan, Leprêtre, Stéphane, Fischer, Kirsten, Kaiser, Florian, Eichhorst, Barbara, Wentner, Clemens-Martin, Hoechstetter, Manuela A, Döhner, Hartmut, Leblond, Veronique, Kneba, Michael, Letestu, Remi, Böttcher, Sebastian, Stilgenbauer, Stephan, Hallek, Michael, Levy, Vincent
Published in Leukemia (01.08.2020)
Published in Leukemia (01.08.2020)
Get full text
Journal Article
Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial
Schmoll, Hans-Joachim, Mann, Julia, Meinert, Fabian, Garlipp, Benjamin, Borchert, Kersten, Vogel, Arndt, Goekkurt, Eray, Kaiser, Ulrich, Hoeffkes, Heinz-Gert, Rüssel, Jörn, Kanzler, Stephan, Edelmann, Thomas, Forstbauer, Helmut, Göhler, Thomas, Hannig, Carla, Hildebrandt, Bert, Roll, Carsten, Bokemeyer, Carsten, Steighardt, Jörg, Cygon, Franziska, Ibach, Stefan, Stein, Alexander, Tintelnot, Joseph
Published in British journal of cancer (01.02.2024)
Published in British journal of cancer (01.02.2024)
Get full text
Journal Article
Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcome
Steinbrecher, Daniela, Jebaraj, Billy Michael Chelliah, Schneider, Christof, Edelmann, Jennifer, Cymbalista, Florence, Leblond, Véronique, Delmer, Alain, Ibach, Stefan, Tausch, Eugen, Scheffold, Annika, Bloehdorn, Johannes, Hallek, Michael, Dreger, Peter, Döhner, Hartmut, Stilgenbauer, Stephan
Published in Leukemia & lymphoma (03.07.2018)
Published in Leukemia & lymphoma (03.07.2018)
Get full text
Journal Article
Predictive Value of Preoperative Endoscopic Ultrasound (EUS) After Neoadjuvant Chemotherapy in Locally Advanced Esophagogastric Cancer - Data From a Randomized German Phase II Trial
Sivanathan, Visvakanth, Utz, Christoph, Thomaidis, Thomas, Förster, Friedrich, Stahl, Michael, Lordick, Florian, Ibach, Stefan, Kanzler, Stephan, Adler, Andreas, Mönig, Stefan Paul, Schimanski, Carl C, Ignee, Andre, Dietrich, Christoph F, Galle, Peter R, Moehler, Markus
Published in Ultraschall in der Medizin (01.10.2022)
Published in Ultraschall in der Medizin (01.10.2022)
Get more information
Journal Article
Intraperitoneal immunotherapy with the bispecific anti-EpCAM x anti-CD3 directed antibody catumaxomab for patients with peritoneal carcinomatosis from gastric cancer: Final results of a randomized phase II AIO trial
Lordick, Florian, Kunzmann, Volker, Trojan, Jorg, Daum, Severin, Schenk, Michael, Kullmann, Frank, Schroll, Sebastian, Behringer, Dirk M., Stahl, Michael, Al-Batran, Salah-Eddin, Ibach, Stefan, Koerfer, Justus, Knoedler, Maren Kristina
Published in Journal of clinical oncology (01.02.2018)
Published in Journal of clinical oncology (01.02.2018)
Get full text
Journal Article
Su1129 – Predictive Significance of Endosonographic (EUS) Staging in Locally Advanced Gastric (GC) Or Gastroesophagealjunction (AEG) Adenocarcinoma: Analysis of Data from a Perioperative Aio-Cao Phase Ii Study
Sivanathan, Visvakanth, Thomaidis, Thomas, Stahl, Michael, Utz, Christoph, Maderer, Annett, Lordick, Florian, Mihaljevic, André, Kanzler, Stephan, Höhler, Thomas, Thuss-Patience, Peter, Moenig, Stefan, Kunzmann, Volker, Schroll, Sebastian, Ibach, Stefan, Tannapfel, Andrea, Meyer, Hans-Joachim, Schuhmacher, Christoph, Wilke, Hans Jochen, Krause, Katrin, Karatas, Aysun, Galle, Peter R., Moehler, Markus
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2019)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2019)
Get full text
Journal Article
High-Resolution SNP-Array Profiling of “Ultra-High Risk” CLL Cases Reveals New Recurrent Genomic Alterations
Edelmann, Jennifer, Holzmann, Karlheinz, Tausch, Eugen, Dolnik, Anna, Blätte, Tamara J., Ibach, Stefan, Saub, Jenny, Mertens, Daniel, Bullinger, Lars, Fischer, Kirsten, Goede, Valentin, Gribben, John G., Hallek, Michael J., Döhner, Hartmut, Stilgenbauer, Stephan
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Genomic Mechanisms of 17p / TP53 Loss in Primary “ultra High-risk” and Refractory Chronic Lymphocytic Leukemia: Results from the CLL2O Trial
Teleanu, Veronica, Edelmann, Jennifer, Haferlach, Claudia, Ibach, Stefan, Tausch, Eugen, Bloehdorn, Johannes, Leblond, Veronique, Cymbalista, Florence, Delmer, Alain, Hallek, Michael, Doehner, Hartmut, Stilgenbauer, Stephan
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
High Resolution Genomic Profiling of Primary “Ultra High Risk” and Refractory Chronic Lymphocytic Leukemia: Results from the CLL2O Trial
Edelmann, Jennifer, Saub, Jenny, Ibach, Stefan, Holzmann, Karlheinz, Tausch, Eugen, Bloehdorn, Johannes, Mertens, Daniel, Zenz, Thorsten, Cymbalista, Florence, Leblond, Veronique, Delmer, Alain, Gribben, John G., Hallek, Michael, Döhner, Hartmut, Stilgenbauer, Stephan
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Alemtuzumab Combined with Dexamethasone, Followed By Alemtuzumab Maintenance or Allo-SCT in “ultra High-risk” CLL: Final Results from the CLL2O Phase II Study
Stilgenbauer, Stephan, Cymbalista, Florence, Leblond, Véronique, Delmer, Alain, Ibach, Stefan, Choquet, Sylvain, Dartigeas, Caroline, Cazin, Bruno, Tournilhac, Olivier, Pegourie, Brigitte, Seiler, Till M, Sökler, Martin, Zirlik, Katja, Alt, Jürgen, Huber, Henriette, Bloehdorn, Johannes, Tausch, Eugen, Zenz, Thorsten, Hallek, Michael, Schetelig, Johannes, Dreger, Peter, Döhner, Hartmut
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Early Versus Deferred Treatment With Combined Fludarabine, Cyclophosphamide and Rituximab (FCR) Improves Event-Free Survival In Patients With High-Risk Binet Stage A Chronic Lymphocytic Leukemia – First Results Of a Randomized German-French Cooperative Phase III Trial
Schweighofer, Carmen D, Cymbalista, Florence, Müller, Carolin, Busch, Raymonde, Porcher, Raphael, Langerbeins, Petra, Cazin, Bruno, Fink, Anna-Maria, Dreyfus, Brigitte, Ibach, Stefan, Leprêtre, Stéphane, Fischer, Kirsten, Vehling-Kaiser, Ursula, Eichhorst, Barbara, Bergmann, Manuela A., Stilgenbauer, Stephan, Döhner, Hartmut, Leblond, Veronique, Hallek, Michael, Levy, Vincent
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW
Stilgenbauer, Stephan, Cymbalista, Florence, Leblond, Veronique, Delmer, Alain, Mack, Silja, Bühler, Andreas, Winkler, Dirk, Zenz, Thorsten, Busch, Raymonde, Ibach, Stefan, Choquet, Sylvain, Caroline, Dartigeas, Cazin, Bruno, Tournilhac, Olivier, Seiler, Till M, Zirlik, Katja, Alt, Jürgen, Sökler, Martin, Schetelig, Johannes, Dreger, Peter, Hallek, Michael, Döhner, Hartmut
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
Prognostic Impact of Chromosomal Abnormalities in Elderly Patients with Multiple Myeloma Treated with High-Dose Melphalan (MEL140) and Autologous Stem Cell Transplantation
Liebisch, Peter, Straka, Christian, Wimmer, Astrid, Wendl, Christiane, Hinke, Axel, Ibach, Stefan, Döhner, Hartmut
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article